Emcure Pharmaceuticals’ arm inks pact with Manx Healthcare

04 Apr 2025 Evaluate

Emcure Pharmaceuticals’ a subsidiary -- Tillomed Laboratories has entered into an Asset Purchase Agreement (APA) with UK based Manx Healthcare and its subsidiaries Manx Pharma and Manx Generics (collectively Manx). 

Under the APA, Tillomed will acquire Manx’s product portfolio inclusive of relevant Dossiers, Marketing Authorisations, Intellectual Property (collectively Intellectual Properties) and the relevant stocks for around 19.7 million pound (including 4.7 million pound for inventory) of which 6.2 million pound will be upfront and rest payments over the next 18 months.

Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.

Emcure Pharma Share Price

1395.15 -9.10 (-0.65%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×